Amitriptyline Hydrochloride Oral Solution
Amitriptyline Hydrochloride is an oral liquid medicine used to treat mental health difficulties and headaches.
Amitriptyline Hydrochloride is indicated for the following:
The treatment of major depressive disorder in adults
The treatment of neuropathic pain in adults
The prophylactic treatment of chronic tension type headache (CTTH) in adults
The prophylactic treatment of migraine in adults
The treatment of nocturnal enuresis in children aged 6 years and above when organic pathology, including spina bifida and related disorders, have been excluded and no response has been achieved to all other non-drug and drug treatments, including antispasmodics and vasopressin-related products. This medicinal product should only be prescribed by a healthcare professional with expertise in the management of persistent enuresis.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Amitriptyline Hydrochloride Oral Solution. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Amitriptyline Hydrochloride Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.
Amitriptyline Hydrochloride Oral Solution
Click here for Audio Version | |
Flavour | Fruit cup and orange |
Storage Conditions | Store below 25°C, Protect from light |
Sucrose Free | |
Shelf Life (Closed Bottle/Open Bottle) | 24 months /6 months |
PIP Code | 1079300 |
EAN Code | 50-16119-06989-5 |
Sodium Levels | None |
Ethanol Concentration | 0.11mg/5ml |
Downloads
Click here for Audio Version | |
Flavour | Fruit cup |
Storage Conditions | Store below 25°C. Protect from light |
Sucrose Free | |
Shelf Life (Closed Bottle/Open Bottle) | 24 months /6 months |
PIP Code | 107-9318 |
EAN Code | 50-16119-07089-1 |
Sodium Levels | None |
Ethanol Concentration | None |
Downloads
Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.
Contact us
For further product information and pricing please use the form below and a member of the team will be in touch
[contact-form-7 id="275" title="Contact form 1" html_class="two-col-contact-form"]Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.